Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 3, 2012, Pages 297-306

  González, Frank ^a   Sreekumaran Nair, K ^b   Daniels, Janice K ^b   Basal, Eati ^b   Schimke, Jill M ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Androgens; Hyperglycemia; Nuclear factor B

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; GLUCOSE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PRASTERONE; PROTEIN P105; SYNAPTOTAGMIN I; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERANDROGENISM; INSULIN SENSITIVITY; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE FITNESS; TREATMENT RESPONSE;

ADULT; BODY MASS INDEX; CELL NUCLEUS; CYTOKINES; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERANDROGENISM; HYPERGLYCEMIA; I-KAPPA B PROTEINS; LEUKOCYTES, MONONUCLEAR; NF-KAPPA B; POLYCYSTIC OVARY SYNDROME; PROTEIN SUBUNITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE CONGENERS; YOUNG ADULT;

EID: 84856143275     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00416.2011     Document Type: Article

References (54)

1. Aljada A, Ghanim H, Dandona P. Translocation of p47phox and activation of NADPH oxidase in mononuclear cells. Methods Molec Biol 196: 99-103, 2002.
2. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limited numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.
3. Aoki K, Saito T, Satoh S, Mukasa K, Kaneshiro M, Kawasaki S, Okamura A, Sehihara H. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phospatase and fructose-1,6-biphosphatase activities in C57BL/Ksj-db/db mice. Diabetes 48: 1579-1585, 1999.
4. Ashcroft GS, Mills SL. Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 110: 615-624, 2002.
5. Balagopal P, Schimke JC, Ades P, Adey D, Nair KS. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab 280: E203-E208, 2001.
6. Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107: 3-6, 2001.
7. Barkhausen T, Hildebrand F, Krettek C, van Griensven M. DHEAdependent and organ-specific regulation of TNF-alpha mRNA expression in a murine polymicrobial sepsis and trauma model. Critical Care 13: R114, 2009.
8. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
9. Burghen GA, Givens JR, Kitabachi AE. Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J Clin Endocrinol Metab 50: 113-116, 1980.
10. Carmina E, Rosato F, Jann- A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91: 2-6, 2006.
11. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Orio F, Di Fede G, Rini G. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 92: 2500-2505, 2007.
12. Ciaraldi TP, Kolterman OG, Olefsky JM. Mechanism for the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity. J Clin Invest 68: 875-878, 1981.
13. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86: 3257-3265, 2001.
14. Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 95: 1048-1058, 2011.
15. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
16. Fain JN, Bahouth SW, Madan AK. TNFalpha release by the nonfat cells of human adipose tissue. Int J Obes 28: 616-622, 2004.
17. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145: 2273-2282, 2004.
18. Fan CM, Maniatis T. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway. Nature 354: 395-398, 1991.
19. Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A, Dandona P. Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia 50: 278-285, 2007.
20. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110: 1564-1571, 2004.
21. González F, Minium J, Rote NS, Kirwan JP. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 5336-5342, 2005.
22. González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen speciesinduced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91: 336-340, 2006.
23. González F, Rote NS, Minium J, Kirwan JP. Increased activation of nuclear factor κB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 91: 1508-1512, 2006.
24. González F, Rote NS, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-α release in obese women with polycystic ovary syndrome. J Endocrinol 188: 521-529, 2006.
25. González F, Minium J, Rote NS, Kirwan JP. Altered tumor necrosis factor- α release from mononuclear cells of obese reproductive age women during hyperglycemia. Metabolism 55: 271-277, 2006.
26. González F, Rote NS, Minium J, O'Leary VB, Kirwan JP. Obese reproductive age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity 15: 2436-2444, 2007.
27. González F, Rote NS, Minium J, Kirwan JP. Insulin sensitivity and hyperandrogenism in polycystic ovary syndrome are related to activated nuclear factor κB from mononuclear cells in the fasting state. Program of the 89th Annual Meeting of the Endocrine Society, Toronto, ON, Canada, 2007, p. 142.
28. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91: 4854-4858, 1994.
29. Jones NH. Finding the area under the curve using jmp and a trapezoidal rule [Online]. SAS Institute. http://www.jmp.com/about/newsletters/jmpercable/pdf/05_fall_1997.pdf [1997].
30. Kimura M, Tanaka S, Yamada Y, Kiuchi Y, Yamakawa T, Sekihara H. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology 139: 3249-3253, 1998.
31. Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16: 1255-1260, 2001.
32. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am J Physiol Endocrinol Metab 281: E1137-E1143, 2001.
33. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity. Evidence for receptor and post receptor defects. J Clin Invest 65: 1272-1284, 1980.
34. Knochenhauer ES, Key TJ, Kahser-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern Unites States: a prospective study. J Clin Endocrinol Metab 83: 3078-3082, 1998.
35. Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 27: 2033-2040, 2004.
36. Linné Y. Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 5: 137-143, 2004.
37. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25: 544-551, 2010.
38. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470, 1999.
39. Modan M, Harris MI, Halkin H. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes 38: 1630-1635, 1989.
40. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83: 2001-2005, 1998.
41. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A, Liu-Bryan R, Glass CK, Neels JG, Olefsky JM. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282: 35279-35292, 2007.
42. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309, 2008.
43. Ripple MO, Henry WF, Schwarze SR, Wilding G, Weindruch R. Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNAbinding activity in prostate carcinoma cells. J Natl Cancer Inst 14: 1227-1232, 1999.
44. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25, 2004.
45. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107: 181-189, 2001.
46. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7-11, 2001.
47. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 67: 44-49, 1998.
48. Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, Starks T, Gurley C, Simpson P, McGehee RE Jr, Kern PA, Peterson CA. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296: E1300-E1310, 2009.
49. Waggoner W, Boots LR, Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol 13: 394-400, 1999.
50. Webster RA. Reproductive function and pregnancy. In: Henry's Clinical Diagnosis and Management by Laboratory Methods (21st ed.), edited by McPherson RA and Pincus MR. Philadelphia, PA: Saunders Elsevier, 2006, chapt. 25, p. 364-378.
51. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808, 2003.
52. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830, 2003.
53. Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 79: 1358-1364, 2003.
54. Zhang Z, Araghi-Niknam M, Liang B, Inserra P, Ardestani SK, Jiang S, Chow S, Watson RR. Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection. Immunology 96: 291-297, 1999.